Gastric sleeve surgery is one of the most commonly performed bariatric procedures in the UK, offering a clinically proven approach to significant, sustained weight loss for eligible adults. Formally known as sleeve gastrectomy, the operation removes approximately 75–80% of the stomach, reducing capacity and suppressing the hunger hormone ghrelin. Whether you are exploring NHS referral pathways, assessing your eligibility under NICE guidance, or researching what recovery involves, this article provides clear, evidence-based information to help you make an informed decision about gastric sleeve surgery.

What Is Gastric Sleeve Surgery and How Does It Work

Gastric sleeve surgery removes 75–80% of the stomach laparoscopically, creating a narrow sleeve that restricts intake and reduces ghrelin production, also influencing gut hormones GLP-1 and PYY to improve satiety and blood glucose regulation.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is a type of bariatric (weight-loss) surgery in which approximately 75–80% of the stomach is surgically removed, leaving a narrow, sleeve-shaped pouch roughly the size of a banana. This significantly reduces the stomach's capacity, meaning patients feel full much more quickly after eating smaller portions.

Beyond simple restriction, the procedure also has important hormonal effects. The portion of the stomach removed contains the majority of cells responsible for producing ghrelin — often referred to as the 'hunger hormone' — and its removal helps to suppress appetite. The surgery also influences other gut hormones involved in satiety and metabolism, including GLP-1 (glucagon-like peptide-1) and PYY (peptide YY), which contribute to improved blood glucose regulation and reduced hunger over the longer term.

The operation is typically performed laparoscopically (keyhole surgery), using small incisions and a camera to guide the surgical instruments. This minimally invasive approach generally results in shorter hospital stays, reduced post-operative pain, and faster recovery compared with open surgery. Gastric sleeve surgery does not involve rerouting the intestines, which distinguishes it from procedures such as gastric bypass.

It is important to understand that the removed portion of the stomach cannot be restored; however, if clinically indicated, revision or conversion to another bariatric procedure may be considered in the future. NICE recommends bariatric surgery for eligible adults, and NHS services commission surgery in line with NICE guidance (CG189) and local Integrated Care Board (ICB) policies.

Who Is Eligible for Gastric Sleeve Surgery in the UK

NICE CG189 recommends bariatric surgery for adults with a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with an obesity-related condition, following unsuccessful non-surgical weight management; lower BMI thresholds may apply for some minority ethnic groups.

In the United Kingdom, eligibility for gastric sleeve surgery is guided by NICE Clinical Guideline CG189 (Obesity: identification, assessment and management) and NHS commissioning criteria. Generally, bariatric surgery is considered for adults who meet the following criteria:

• BMI of 40 kg/m² or above, or

• BMI of 35–39.9 kg/m² with a significant obesity-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea

• Bariatric surgery should be offered as a first-line option to adults with a BMI of 35 kg/m² or above and recent-onset type 2 diabetes (diagnosed within the past 10 years)

• In some cases, individuals with a BMI of 30–34.9 kg/m² and recent-onset type 2 diabetes (within 10 years) may also be considered for surgery

It is worth noting that lower BMI thresholds for assessment may be appropriate for people from some minority ethnic groups, who are at higher cardiometabolic risk at lower BMI values. Clinicians should consider this when assessing individual patients.

Patients must also have demonstrated that non-surgical weight management interventions — including dietary changes, increased physical activity, and behavioural support (such as Tier 3 weight management services where locally commissioned) — have been tried and have not achieved or maintained adequate weight loss. A commitment to long-term lifestyle changes and follow-up is essential.

A thorough pre-operative assessment is conducted by a multidisciplinary team (MDT), which typically includes a bariatric surgeon, dietitian, psychologist, and specialist nurse. This assessment evaluates physical health, mental health, nutritional status, and the patient's understanding of the procedure and its implications. Pre-operative requirements typically include smoking cessation, moderation of alcohol intake, and optimisation of any existing health conditions. Certain conditions, such as uncontrolled psychiatric illness or active substance misuse, may temporarily or permanently preclude surgery.

Patients are encouraged to discuss their individual circumstances with their GP as a first step towards referral. Local ICB commissioning policies and Royal College of Surgeons/BOMSS commissioning standards provide further guidance on eligibility and referral pathways.

What to Expect Before, During and After the Procedure

Patients follow a high-protein liver-shrinking diet for two to four weeks pre-operatively; surgery takes 60–90 minutes under general anaesthesia, with a one-to-two night stay and a staged dietary progression from liquids to solids over six weeks.

The pre-operative phase typically begins several weeks before surgery and involves a structured preparation programme. Patients are usually required to follow a high-protein, low-calorie liver-shrinking diet for two to four weeks prior to the operation. This reduces the size of the liver, making surgery safer and technically easier. Blood tests, imaging, and specialist consultations are completed during this period to ensure the patient is medically optimised.

On the day of surgery, the procedure is performed under general anaesthesia and typically takes between 60 and 90 minutes. Using laparoscopic instruments, the surgeon divides and removes the larger portion of the stomach, stapling the remaining sleeve securely. Standard peri-operative care includes measures to reduce the risk of venous thromboembolism (VTE), such as compression stockings, anticoagulant prophylaxis, and early mobilisation after surgery. Most patients remain in hospital for one to two nights post-operatively, during which pain management, hydration, and mobilisation are closely monitored.

In the immediate post-operative period, patients progress through a carefully staged dietary plan guided by their bariatric MDT. Whilst specific timings vary by centre, a typical progression is:

• Week 1–2: Full liquids, including protein drinks, smooth soups, and milk-based fluids (not limited to clear fluids alone)

• Week 3–4: Pureed and soft foods

• Week 5–6: Gradual reintroduction of solid foods

Post-operative medications commonly include a proton pump inhibitor (PPI) for several months to protect the stomach lining and reduce the risk of reflux or ulceration. Where locally used, ursodeoxycholic acid may be prescribed for a period after surgery to reduce the risk of gallstone formation. Patients should take all prescribed medications as directed and discuss any concerns with their bariatric team.

Regular follow-up appointments with the bariatric team are scheduled at intervals of approximately one month, three months, six months, and annually. BOMSS recommends that specialist follow-up continues for at least two years after surgery; thereafter, ongoing care is typically shared with the patient's GP, with lifelong annual blood tests to monitor nutritional status and overall health. Patients are advised to attend all follow-up appointments, as early identification of complications or nutritional deficiencies is critical to long-term success.

Risks, Side Effects and Long-Term Considerations

Short-term risks include staple line leakage and blood clots; long-term considerations include GORD, nutritional deficiencies, gallstones, and sleeve dilation, with lifelong monitoring and supplementation required.

As with any major surgical procedure, gastric sleeve surgery carries both short-term and long-term risks. It is important that patients receive balanced, evidence-based information to make a fully informed decision.

Short-term risks include:

• Bleeding or infection at the surgical site

• Leakage from the staple line (a rare but serious complication)

• Blood clots (deep vein thrombosis or pulmonary embolism)

• Adverse reactions to anaesthesia

• Stricture or narrowing of the sleeve

Longer-term considerations include:

• Gastro-oesophageal reflux disease (GORD): Some patients experience worsening or new-onset acid reflux following sleeve gastrectomy. Initial management typically involves PPI therapy; patients with persistent or severe symptoms should seek review from their bariatric team, as further investigation or treatment may be required.

• Nutritional deficiencies: Reduced food intake can lead to deficiencies in vitamin B12, iron, vitamin D, folate, and calcium. Thiamine (vitamin B1) deficiency is a particular risk in patients experiencing prolonged vomiting and requires prompt assessment. Lifelong supplementation and regular blood monitoring are essential (see the Diet and Lifestyle section below).

• Gallstones: Rapid weight loss increases the risk of gallstone formation. Ursodeoxycholic acid may be prescribed in the months following surgery where this is local practice.

• Sleeve dilation or weight regain: A small proportion of patients may experience gradual dilation of the sleeve or weight regain over time, particularly if dietary and lifestyle recommendations are not maintained.

• Psychological adjustment: Changes in body image and eating habits can affect mental health. Ongoing psychological support is an important component of aftercare.

When to seek urgent help: Patients should call 999 or attend the nearest emergency department immediately if they experience:

• Severe chest pain or difficulty breathing

• Shortness of breath or rapid heart rate

• Unilateral calf pain, swelling, or redness (possible DVT)

Patients should seek urgent review from their GP or bariatric team if they experience:

• Severe or worsening abdominal pain

• Fever or signs of infection

• Persistent vomiting or inability to keep fluids down

• Signs of nutritional deficiency such as extreme fatigue, hair loss, or numbness in the hands or feet

Reporting side effects: If you experience a suspected side effect from a medicine or a problem related to a surgical device used during your procedure, you can report this to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Diet, Lifestyle and Recovery Following Gastric Sleeve Surgery

Long-term success requires small frequent protein-rich meals, lifelong vitamin and mineral supplementation per BOMSS guidance, at least 150 minutes of moderate aerobic activity weekly, and avoiding pregnancy for 12–18 months post-surgery.

Long-term success following gastric sleeve surgery depends heavily on sustained dietary and lifestyle changes. The surgery is a tool, not a cure — patients who engage actively with post-operative guidance consistently achieve better outcomes.

Dietary principles after surgery include:

• Eating small, frequent meals (typically five to six small portions per day)

• Chewing food thoroughly and eating slowly

• Prioritising protein-rich foods (lean meat, fish, eggs, dairy, legumes) at each meal

• Avoiding high-sugar and high-fat foods, which can cause discomfort

• Separating fluid intake from meals — drinking between meals rather than with food

• Aiming for approximately 1.5–2 litres of fluid per day (unless advised otherwise by your clinical team)

• Avoiding carbonated drinks and alcohol, particularly in the early post-operative period

Lifelong vitamin and mineral supplementation is essential following sleeve gastrectomy. In line with BOMSS guidance, patients are typically advised to take:

• A bariatric-specific multivitamin and mineral supplement daily

• Calcium with vitamin D (in divided doses to aid absorption)

• Iron supplementation, particularly for women of childbearing age

• Vitamin B12 (oral or intramuscular injection, depending on absorption)

• Folate, as directed by the bariatric team

• Thiamine (vitamin B1) if experiencing prolonged nausea or vomiting

Regular blood tests — typically at three months, six months, and annually thereafter — are used to monitor nutritional status and guide any adjustments to supplementation. Patients should not stop or change supplements without discussing this with their bariatric team or GP.

Physical activity plays a vital role in maintaining weight loss and improving cardiovascular health. Patients are generally advised to begin with gentle walking in the early weeks, gradually increasing activity levels. In line with UK Chief Medical Officers' guidelines, the aim is to achieve at least 150 minutes of moderate-intensity aerobic activity per week (or 75 minutes of vigorous-intensity activity), alongside muscle-strengthening activities on at least two days per week to help preserve muscle mass during weight loss.

Pregnancy and contraception: Women of childbearing age are advised to avoid becoming pregnant for at least 12–18 months after bariatric surgery, as rapid weight loss during this period can affect foetal development and nutritional status. Long-acting reversible contraception (LARC), such as an intrauterine device or implant, is recommended during this time, as some oral contraceptives may be less reliably absorbed after surgery. Women who are already pregnant or who become pregnant after surgery should inform their obstetric team promptly so that appropriate monitoring and nutritional support can be arranged.

Emotional wellbeing should not be overlooked. Many patients benefit from ongoing support groups, counselling, or bariatric-specific psychological services, which can help address the emotional aspects of significant weight loss and body image changes.

Finding Accredited Bariatric Services and Support

NHS bariatric surgery is commissioned through Integrated Care Boards; patients should start with their GP for referral, and choose CQC-registered private providers with full MDT support accredited to BOMSS and Royal College of Surgeons standards.

In the United Kingdom, bariatric surgery is available through both the NHS and the independent (private) sector. NHS-funded surgery is commissioned through Integrated Care Boards (ICBs) and is subject to local eligibility criteria, which may vary slightly by region. For most patients, the first step is to speak with their GP, who can assess eligibility, support referral into Tier 3 weight management services where these are locally commissioned, and initiate onward referral to a specialist bariatric service.

For those considering private treatment, it is important to choose a service accredited by a recognised body. The British Obesity and Metabolic Surgery Society (BOMSS) and the Royal College of Surgeons provide guidance on standards of care, and patients should look for centres that offer comprehensive MDT support, including dietetic, psychological, and surgical expertise. The Care Quality Commission (CQC) regulates and inspects independent healthcare providers in England; their inspection reports and provider ratings are publicly available via the CQC website (cqc.org.uk), where patients can search for and compare registered services.

The National Bariatric Surgery Registry (NBSR) collects audited outcomes data from UK bariatric centres and surgeons, and can be a useful resource for patients wishing to understand the quality and safety record of services they are considering.

Support organisations can be invaluable throughout the bariatric journey:

• BOMSS (bomss.org.uk) — professional guidance and patient resources

• WLS Info — a UK-based patient support community

• NHS Weight Loss Surgery pages — accessible via nhs.uk

• Obesity UK — advocacy and peer support

Patients are encouraged to approach their decision thoughtfully, seeking information from reputable UK sources and engaging fully with pre- and post-operative support services. Bariatric surgery can be a life-changing intervention when undertaken with appropriate preparation, realistic expectations, and a genuine commitment to long-term lifestyle change.

Frequently Asked Questions